Detalhe da pesquisa
1.
XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression.
Cell Death Dis
; 15(5): 330, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740827
2.
MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells.
Cell Death Discov
; 10(1): 9, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182558
3.
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
J Thorac Oncol
; 19(3): 434-450, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924972
4.
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.
Cancer Res Commun
; 4(5): 1268-1281, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619287
5.
MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression.
Oncogene
; 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38802648
6.
MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression.
Commun Biol
; 6(1): 1030, 2023 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821650
7.
MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer.
Cancer Lett
; 559: 216116, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878307
8.
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754452
9.
MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells.
iScience
; 26(11): 108168, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37915591
10.
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Mol Cancer Res
; 21(3): 274-289, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36445328
11.
Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer.
Mol Cancer Res
; 20(9): 1379-1390, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612556
12.
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment.
Oncogene
; 41(27): 3511-3523, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688945
13.
Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification.
IJU Case Rep
; 4(4): 216-219, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258530
14.
Splenic cord capillary hemangioma with non-islet cell tumor hypoglycemia: a case report.
Diagn Pathol
; 14(1): 135, 2019 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31842913
15.
Prognostic significance of erythrocyte protein band 4.1-like5 expression in upper urinary tract urothelial carcinoma.
Urol Oncol
; 35(9): 543.e17-543.e24, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28483476
16.
A metastatic castration resistant prostate cancer patient with multiple bone metastases has durable biochemical and radiological response to docetaxel chemotherapy.
Am J Clin Exp Urol
; 4(2): 28-31, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27766278
17.
The prognostic significance of OCT4 expression in patients with prostate cancer.
Hum Pathol
; 51: 1-8, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067776
18.
Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy?
J Endourol
; 26(9): 1199-202, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22524402